DHI
45
2
LEN
52
4
BK
66
-3
CCI
28
3
SLG
62
3
ABBV
57
-2
COP
54
4
EXR
48
2
RSG
60
3
AAP
30
3
NAVI
43
16
WAT
66
2
OI
28
3
STT
60
7
DVA
59
4
CSX
55
-2
EA
59
5
CHRW
50
13
TRV
46
-3
CNP
44
8
DHI
45
2
LEN
52
4
BK
66
-3
CCI
28
3
SLG
62
3
ABBV
57
-2
COP
54
4
EXR
48
2
RSG
60
3
AAP
30
3
NAVI
43
16
WAT
66
2
OI
28
3
STT
60
7
DVA
59
4
CSX
55
-2
EA
59
5
CHRW
50
13
TRV
46
-3
CNP
44
8
Financhill
Back

X4 Pharmaceuticals 10K Form

Sell
40

XFOR
X4 Pharmaceuticals

Last Price:
0.52
Seasonality Move:
9.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive XFOR News And Ratings

See the #1 stock for the next 7 days that we like better than XFOR

XFOR Financial Statistics

Sales & Book Value

Annual Sales: $3M
Cash Flow: $-37.41M
Price / Cash Flow: 0
Annual Sales: $0.56
Price / Book: 0.94

Profitability

EPS (TTM): 0.09000
Net Income (TTM): $17.63M
Gross Margin: --
Return on Equity: 31.29%
Return on Assets: 10.79%

X4 Pharmaceuticals Earnings Forecast

Key X4 Pharmaceuticals Financial Ratios

  • The Interest Expense is -5.71% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

X4 Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: XFOR
CUSIP: 98420X
Website: x4pharma.com

Debt

Debt-to-Equity Ratio: 0.79
Current Ratio: 6.07
Quick Ratio: 5.87

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XFOR Technical Analysis vs Fundamental Analysis

Sell
40
X4 Pharmaceuticals (XFOR) is a Sell

Is X4 Pharmaceuticals a Buy or a Sell?